AMJ Financial Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-14,930
Closed -$8.65M 99
2025
Q4
$8.65M Buy
+14,930
New +$8.44M 2.05% 25
2023
Q2
Sell
-4,987
Closed -$2.87M 87
2023
Q1
$2.87M Buy
4,987
+70
+1% +$39.5K 1.85% 19
2022
Q4
$2.71M Sell
4,917
-3,435
-41% -$1.82M 1.6% 21
2022
Q3
$4.24M Sell
8,352
-687
-8% -$384K 2.75% 15
2022
Q2
$4.91M Buy
9,039
+45
+0.5% +$24.8K 4.15% 9
2022
Q1
$5.31M Sell
8,994
-2,651
-23% -$1.52M 2.13% 25
2021
Q4
$7.77M Buy
11,645
+4,054
+53% +$2.53M 2.8% 13
2021
Q3
$4.34M Buy
7,591
+2,979
+65% +$1.64M 1.78% 25
2021
Q2
$2.33M Sell
4,612
-7,401
-62% -$3.49M 1.01% 36
2021
Q1
$5.48M Buy
12,013
+451
+4% +$215K 2.65% 11
2020
Q4
$5.38M Sell
11,562
-43
-0.4% -$20.2K 2.75% 12
2020
Q3
$5.12M Sell
11,605
-174
-1% -$71.9K 3.02% 11
2020
Q2
$4.27M Buy
11,779
+7,479
+174% +$2.51M 2.91% 10
2020
Q1
$1.22M Sell
4,300
-7,783
-64% -$2.45M 2.12% 16
2019
Q4
$3.92M Buy
+12,083
New +$3.66M 2.76% 14

Other funds holding TMO

AMJ Financial Wealth Management's TMO Position: Q1 2026 in Review

AMJ Financial Wealth Management sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 14,930 shares — an estimated $8.65M sold.

AMJ Financial Wealth Management first reported a position in TMO in Q4 2019 and held it in 15 quarters. The position peaked at $8.65M in Q4 2025. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • AMJ Financial Wealth Management reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • AMJ Financial Wealth Management sold 14,930 Thermo Fisher Scientific shares in Q1 2026, an estimated $8.65M.
  • AMJ Financial Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2019 and held it in 15 quarters.
  • AMJ Financial Wealth Management's Thermo Fisher Scientific position peaked at $8.65M in Q4 2025.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on AMJ Financial Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.